Skip to main content

FDA panel endorses Johnson & Johnson COVID-19 vaccine booster with 2-month gap for ages 18 and up

A Food and Drug Administration (FDA) advisory committee on Friday endorsed an emergency authorization for the Johnson & Johnson COVID-19 vaccine booster when administered at least two months after the initial dose among people ages 18 years and older.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.